Being Health

Being Health in Manhattan, New York offers Spravato (esketamine), an FDA-approved intranasal spray used alone or alongside an oral antidepressant to treat adults with treatment-resistant depression and major depressive disorder with acute suicidal ideation. Rather than targeting serotonin or norepinephrine like traditional antidepressants, esketamine acts on glutamate, often providing rapid improvement in depressive symptoms.

Treatment begins with a 60-minute interventional psychiatry consultation to determine eligibility. During each two-hour session, patients self-administer the nasal spray under the supervision of a healthcare provider and are continuously monitored, with the option of a Wavepaths immersive audio experience.

Board-certified psychiatrists and emergency medicine physicians oversee every session in a comfortable clinical setting. Being Health integrates Spravato with therapy and nutrition support, and is in-network with Aetna, Cigna, UnitedHealthcare, Optum, Oscar, and Northwell Direct, with rebate programs reducing eligible costs to as low as $10 per session.